Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

OXPHOS toxicogenomics and Parkinson's disease.

López-Gallardo E, Iceta R, Iglesias E, Montoya J, Ruiz-Pesini E.

Mutat Res. 2011 Nov-Dec;728(3):98-106. doi: 10.1016/j.mrrev.2011.06.004. Epub 2011 Jul 8. Review.

PMID:
21763451
2.

Mitochondrial oxidative phosphorylation defects in Parkinson's disease.

Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC.

Ann Neurol. 1991 Sep;30(3):332-9.

PMID:
1952821
3.

Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.

Fosslien E.

Ann Clin Lab Sci. 2001 Jan;31(1):25-67. Review.

PMID:
11314862
4.

Mitochondria in the etiology and pathogenesis of Parkinson's disease.

Schapira AH, Gu M, Taanman JW, Tabrizi SJ, Seaton T, Cleeter M, Cooper JM.

Ann Neurol. 1998 Sep;44(3 Suppl 1):S89-98. Review.

PMID:
9749579
5.

Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups.

Gómez-Durán A, Pacheu-Grau D, López-Gallardo E, Díez-Sánchez C, Montoya J, López-Pérez MJ, Ruiz-Pesini E.

Hum Mol Genet. 2010 Sep 1;19(17):3343-53. doi: 10.1093/hmg/ddq246. Epub 2010 Jun 21.

PMID:
20566709
6.

Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients.

DiDonato S, Zeviani M, Giovannini P, Savarese N, Rimoldi M, Mariotti C, Girotti F, Caraceni T.

Neurology. 1993 Nov;43(11):2262-8.

PMID:
8232940
7.

Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease.

Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR.

Neurology. 2000 Feb 8;54(3):703-9.

PMID:
10680807
8.

Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease.

Le Couteur DG, Muller M, Yang MC, Mellick GD, McLean AJ.

Rev Environ Health. 2002 Jan-Mar;17(1):51-64. Review.

PMID:
12088093
9.

A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease.

Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, Derbeneva O, Khusainova R, Khidiyatova I, Magzhanov R, Wallace DC.

Ann N Y Acad Sci. 2008 Dec;1147:1-20. doi: 10.1196/annals.1427.001.

PMID:
19076426
10.

Oxidative phosphorylation disease diagnosis.

Shoffner JM.

Semin Neurol. 1999;19(4):341-51. Review.

PMID:
10716657
11.

Mitochondrial myopathies and encephalomyopathies.

Schapira AH, Cock HR.

Eur J Clin Invest. 1999 Oct;29(10):886-98. Review.

PMID:
10583431
12.

Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population.

Huerta C, Castro MG, Coto E, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, Martínez C, Lahoz CH, Alvarez V.

J Neurol Sci. 2005 Sep 15;236(1-2):49-54.

PMID:
15975594
13.

Oxidative phosphorylation diseases and cerebellar ataxia.

Shoffner JM, Kaufman A, Koontz D, Krawiecki N, Smith E, Topp M, Wallace DC.

Clin Neurosci. 1995;3(1):43-53. Review.

PMID:
7614094
14.

Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra.

Noureddine MA, Li YJ, van der Walt JM, Walters R, Jewett RM, Xu H, Wang T, Walter JW, Scott BL, Hulette C, Schmechel D, Stenger JE, Dietrich F, Vance JM, Hauser MA.

Mov Disord. 2005 Oct;20(10):1299-309.

PMID:
15966006
16.

Mitochondrial DNA and Parkinson's disease.

Di Monte DA.

Neurology. 1991 May;41(5 Suppl 2):38-42; discussion 42-3. Review.

PMID:
1904141
17.

Mitogroup: continent-specific clusters of mitochondrial OXPHOS complexes based on nuclear non-synonymous polymorphisms.

Pierron D, Letellier T, Grossman LI.

Mitochondrion. 2012 Mar;12(2):237-41. doi: 10.1016/j.mito.2011.09.005. Epub 2011 Sep 24.

PMID:
21968253
18.

Molecular genetic and clinical aspects of mitochondrial disorders in childhood.

Moslemi AR, Darin N.

Mitochondrion. 2007 Jul;7(4):241-52. Epub 2007 Feb 14. Review.

PMID:
17376748
19.

The transmission of OXPHOS disease and methods to prevent this.

Jacobs LJ, de Wert G, Geraedts JP, de Coo IF, Smeets HJ.

Hum Reprod Update. 2006 Mar-Apr;12(2):119-36. Epub 2005 Sep 30. Review.

PMID:
16199488
20.

Clinical differences in patients with mitochondriocytopathies due to nuclear versus mitochondrial DNA mutations.

Rubio-Gozalbo ME, Dijkman KP, van den Heuvel LP, Sengers RC, Wendel U, Smeitink JA.

Hum Mutat. 2000;15(6):522-32.

PMID:
10862082

Supplemental Content

Support Center